The FDA has approved Tropazone lotion (from Hi-Tech Pharmacal), a prescription dermatological product for the treatment of various dermatological conditions, including atopic dermatitis, allergic contact dermatitis, and radiation dermatitis. Tropazone utilizes Lyphazome nanosphere technology. This delivery system prolongs product activity while enhancing penetration and hydration of the skin.
Tropazone is expected to be available at the end of February 2010.
For more information call (800) 899-3116 or visit www.hitechpharm.com.